Generation Bio Co. (GBIO)
0.4230 -0.0084 (-1.95%) 12:07 ET [NASDAQ]
0.4222 x 600 0.4282 x 500
Realtime by (Cboe BZX)
0.4222 x 600 0.4282 x 500
Realtime 0.4540 +0.0226 (-) 08:57 ET
for Tue, Apr 29th, 2025
Results
download Want to compare other data? Select Fields| Symbol | GBIO | INKT | GDTC | ||
| Company | Generation Bio Co. | Mink Therapeutics Inc | Cytomed Therapeutics Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.4374 | 7.20 | 2.40 | ||
| High | 0.4399 | 7.61 | 2.40 | ||
| Low | 0.4223 | 7.20 | 2.30 | ||
| Last | 0.4234 | 7.61 | 2.36 | ||
| Change | -0.0080 | +0.11 | -0.05 | ||
| % Change | -1.85% | +1.47% | -2.24% | ||
| Volume | 70,009 | 1,692 | 5,362 | ||
| 20-Day Average Volume | 554,544 | 4,075 | 30,078 | ||
| Previous Close | 0.4314 | 7.50 | 2.41 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.3888 | 7.90 | 2.38 | ||
| 20-Day Raw Stochastic | 76.04% | 16.60% | 34.78% | ||
| 20-Day Relative Strength | 44.88% | 45.92% | 48.43% | ||
| Weighted Alpha | -86.65 | -41.58 | +3.44 | ||
| Today's Opinion | 88% Sell | 40% Sell | 8% Sell | ||
| Previous Opinion | 88% Sell | 40% Sell | 8% Sell | ||
| Last Month's Opinion | 100% Sell | 56% Buy | 8% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +3.91% since 04/22/25 | +1.00% since 04/22/25 | +2.86% since 04/22/25 | ||
| Low | 0.4099 on 04/23/25 | 7.20 on 04/29/25 | 2.18 on 04/25/25 | ||
| High | 0.4592 on 04/23/25 | 8.01 on 04/28/25 | 2.50 on 04/28/25 | ||
| 1-Month | |||||
| %Chg | -0.54% since 03/28/25 | -15.73% since 03/28/25 | +6.67% since 03/28/25 | ||
| Low | 0.3160 on 04/09/25 | 7.20 on 04/29/25 | 1.98 on 03/31/25 | ||
| High | 0.4600 on 04/21/25 | 9.67 on 04/01/25 | 2.85 on 04/10/25 | ||
| 3-Month | |||||
| %Chg | -50.50% since 01/29/25 | +15.30% since 01/29/25 | -6.25% since 01/29/25 | ||
| Low | 0.3160 on 04/09/25 | 6.10 on 01/30/25 | 1.98 on 03/31/25 | ||
| High | 0.8657 on 01/30/25 | 13.79 on 02/05/25 | 2.94 on 02/04/25 | ||
| 6-Month | |||||
| %Chg | -82.20% since 10/29/24 | +4.25% since 10/29/24 | +2.56% since 10/29/24 | ||
| Low | 0.3160 on 04/09/25 | 4.56 on 01/28/25 | 1.83 on 11/15/24 | ||
| High | 2.5700 on 11/07/24 | 13.79 on 02/05/25 | 4.05 on 01/06/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 28,909 | 29,748 | 26,365 | ||
| Shares Outstanding, K | 67,013 | 3,966 | 10,940 | ||
| Annual Sales | 19,890,000 | 0 | 0 | ||
| Annual Net Income | -131,670,000 | -9,510,000 | -3,130,000 | ||
| Last Quarter Sales | 4,190,000 | 0 | N/A | ||
| Last Quarter Net Income | -21,380,000 | -1,190,000 | N/A | ||
| 60-Month Beta | 2.78 | 0.15 | -0.26 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.32 on 03/13/25 | -0.62 on 03/18/25 | N/A | ||
| Latest Earnings Date | 05/12/25 | 05/13/25 | 04/28/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||